Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

New patent issues covering Cytoclonal's novel methods of producing paclitaxel

March 15, 1999

New DAG analogues acting as PKC agonists or antagonists

March 15, 1999

Warner-Lambert prepares irreversible tyrosine kinase inhibitors

March 12, 1999

U.K. is country of first launch for Schering-Plough's oral alkylating agent

March 12, 1999

ImClone receives milestone payment for C225 clinical advance

March 12, 1999

Amgen and Praecis to develop and commercialize abarelix

March 12, 1999

New U.S. patent broadens the base of ImmunoGen's TAP technology

March 12, 1999

Techniclone enters licensing agreement for Oncolym with Schering AG

March 12, 1999

NCI to conduct further testing of Lorus anticancer compounds

March 12, 1999

Protein prenylation inhibitors under study at Pierre Fabre for use in cancer, etc.

March 11, 1999

Popular Stories

Today's news in brief
BioWorld
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 24, 2026
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
University of Southern California reports new MAPT aggregation inhibitors
BioWorld Science
The University of Southern California has identified (2-oxo-2H-chromen-3-yl) scaffold-based carboxamide analogues acting as potent microtubule-associated protein...